# Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance

> **NCT02733224** · — · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Patient Non-adherence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02733224
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-03
- **Final completion:** 2018-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733224, "Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02733224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*